Overview
Synerga.Fund S.A. is a Kraków-based joint-stock company listed on the GPW NewConnect market under the ticker SNG. The company operates in the field of cell therapies. It also publishes basic registration and capital data, as well as reporting and corporate documents.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.42
- High
- PLN 0.42
- Low
- PLN 0.42
- Volume
- 6
- Avg. vol.
- 5.87K
- Market cap
- PLN 11.47M
- P/E ratio
- —
- EPS
- -PLN 0.04
- Shares outstanding
- 27.31M
- 52-week
- PLN 0.41 – 0.44
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLMWTNS00010
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 4.05k | USD -2.97k | USD -3.24k |
| Q1 2026 | USD -40.52k | USD -6.48k | USD -6.48k |
| Q4 2025 | USD 27.62k | USD -16.07k | USD -16.32k |
| Q3 2025 | USD 18.83k | USD -502.26 | USD -502.26 |
Results for Q3 2026:Nov 12, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-10-22. Active
92 1020 2906 0000 1002 0376 4073
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 8, 2020 | Call to creditors | |
| Sep 5, 2019 | Call to creditors | |
| Dec 29, 2011 | Commercial Companies Code notice | |
| Dec 6, 2011 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The following are authorized to submit declarations of will on behalf of the company and sign declarations on behalf of the company: - the President of the Management Board acting independently; or - two members of the management board acting jointly; or - one member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Synerga.Fund.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FR FinanceS.A. | $34,120.64 | frfinance.pl | ||
| Startventure@Poland 2 Spółka Ograniczoną Odpowiedzialnością AsiS.K.A. | $11,898.81 | starfinder.eu | ||
| Alternatywna Spółka Inwestycyjna Crescit Fund Goodman & StoneS.K.A. | $694.95 | asicrescit.goodman-stone.com | ||
| ASI Private Wealth Investments Goodman & StoneS.K.A. | $580.47 | asiprotect.goodman-stone.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-10-07 | Share capital change (2,731,000.00 PLN → 2,730,999.00 PLN) | |
| 2019-12-13 | Share capital change (27,310,000.00 PLN → 2,731,000.00 PLN) | |
| 2019-11-21 | Address change (Ul. Malwowa 30, 30-611, Kraków → Ul. Grzegórzecka 67d/26, 31-559, Kraków) | |
| 2017-08-17 | Address change (Ul. Franciszka Klimczaka 17/80, 02-797, Warszawa → Ul. Malwowa 30, 30-611, Kraków) | |
| 2017-08-17 | Name change (Silva Capital Group → Synerga.fund) |
FAQ
Last updated: 2026-07-15